Prophylactic ciprofloxacin drops after tympanostomy tube insertion

Area of Science:

• Otolaryngology
• Infectious Diseases
• Pharmacology

Background:

• Post-tympanostomy otorrhea is a common complication following tympanostomy tube insertion.
• Identifying effective prophylactic measures is crucial for reducing otorrhea incidence.
• Understanding the role of middle ear content in predicting otorrhea is important.

Purpose of the Study:

• To assess the efficacy of prophylactic topical ciprofloxacin drops in preventing post-tympanostomy otorrhea.
• To investigate the correlation between middle ear fluid content and the development of post-tympanostomy otorrhea.

Main Methods:

• A randomized controlled trial involving 150 pediatric patients (3-14 years) undergoing tympanostomy tube insertion.
• Patients were allocated to three groups: control (no drops), single intraoperative dose of ciprofloxacin, or intraoperative dose plus a 5-day postoperative course.
• Otorrhea incidence was compared across groups, with middle ear content documented.

Main Results:

• Topical ciprofloxacin significantly reduced early post-tympanostomy otorrhea rates compared to the control group (8.4% and 8.2% vs. 16.5%, p=0.011).
• A single dose of ciprofloxacin was effective for ears with dry or serous middle ear effusions.
• A 5-day course of ciprofloxacin was indicated for ears containing mucoid or purulent secretions.

Conclusions:

• A single intraoperative dose of topical ciprofloxacin is effective in preventing early post-tympanostomy otorrhea.
• The nature of middle ear content (serous, mucoid, purulent) is a significant predictor of postoperative otorrhea.
• Tailoring the duration of topical antibiotic treatment based on middle ear content can optimize outcomes.